
Release date: 2024-08-09 16:06:53 Article From: Lucius Laos Recommended: 176
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed in many countries and regions around the world, and has achieved significant therapeutic effects and market repercussions in the market.
The price of different versions of Pemigatinib varies depending on factors such as specifications, manufacturer, region, and market availability.
The specification of Pemigatinib produced by Laos Lucius Pharmaceutical Co., Ltd. is 4.5mg*14 tablets, and the price is 1400 yuan, which may change with time, market changes and policy adjustments.
The price of medicines is affected by a variety of factors, and the actual purchase should be based on the price of local pharmacies, hospitals, or official channels.
When buying generic drugs, it is important to choose formal channels and reliable manufacturers to ensure the quality and safety of the drugs.
The generic drug of Pemigatinib is similar to the original drug in terms of efficacy, but the specific effect needs to consider factors such as individual differences, conditions, and treatment needs. Patients should be fully aware of their condition and the doctor's recommendations when choosing a drug, and undergo a thorough evaluation. Physicians should also be mindful of individual patient differences and safety issues when using generic drugs to ensure that patients get the best possible treatment outcomes.
Lucius Pharmaceuticals Ltd.'s generic drugs are widely recognized for their quality and efficacy. These generic drugs not only maintain the efficacy and safety of the original drugs but also have a price advantage, providing patients with more affordable treatment options. The specific drug effect needs to be comprehensively evaluated according to the patient's condition, individual differences, and clinical data. When using generic drugs, patients should follow their doctor's advice and proceed with treatment under the guidance of their doctor.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1612025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3992024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1552025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1732025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1532025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1882025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1682025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1642025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: